Monday February 18, 2019

Delhi records highest dengue cases as national count doubles

0
//
credit: www.radiotnn.com
credit: www.topnews.in
credit: www.topnews.in

By NewsGram Staff-Writer

New Delhi: Number of dengue cases reported in the country went up to 19,704 this year, which is double of the last year’s figures. By the end of August, cases have already crossed 2014’s count of 10,097.

The alarming data also revealed that 41 people have lost their lives till now. Last year 37 deaths were reported due to dengue. However some sort of relief has come in the form of falling fatality rate which has gone down to 0.20 percent.

According to a Health Ministry statement, fatality rate last peaked high in 1996, when casualties rose to 3 percent.

The report also stated that the most number of dengue cases were reported from Delhi with 1,259 cases. Next was Bangalore with 1,139 cases followed by Greater Mumbai and Kolkata with 306 and 187 cases, respectively.

Arunachal’s East Siang district recorded the most number of dengue cases (district wise) in 2015. Out of 1,681 cases reported in Arunachal Pradesh, 1,618 came from East Siang alone. Among other districts, Chittoor in Arunachal had 761 cases, while Thiruvananthapuram (602 cases) and Kasargod (443 cases) comes next in the list.

Looking for a taking major initiative on the issue, the Union Health Ministry is planning to ban rapid diagnostic test kits for dengue. The ministry is in talks with Indian Council of Medical Research (ICMR) for taking the kit off the market because of its poor error rate. Reportedly, the diagnostic test kit falsely indicates majority of cases as positive which only creates confusion among dengue suspects.

Talking about the present scenario in hospitals, Director General, Health Services, Dr. Jagdish Prasad said, “At present hospitals have to notify only those cases in which test has been performed by IgM or Elisa. The rapid test kit sometimes indicates wrong result in as many as 50 percent cases. We are consulting ICMR for issuing a notification to ban the kit.”

Next Story

Cases of Swine Flu Crosses 1,000-Mark in Delhi

The advisory also said that children with mild illness but with predisposing risk factors, pregnant women, persons aged 65 years or older, patients with lung diseases, heart disease, liver disease, kidney disease etc.

0
Swine Flu

As many as 1,011 cases of swine flu (H1N1) were reported from various hospitals in the national capital till Sunday, according to a data released by the government on Monday.

Although the government data does not report any deaths due to H1N1, some city hospitals claim that 11 persons died last month due to the infection.

In entire 2018, only 205 H1N1 cases and two deaths were reported.

Till January 29, the number of cases were 512.

The Delhi government has directed all its hospitals to make local purchases of logistics required to ensure a continuous supply of medicine, vaccine and kits.

Representational image.

“All government hospitals are equipped with the necessary logistics required for the management of Seasonal Influenza A (H1N1),” the government said in a statement.

A health advisory has also been issued in both Hindi and English by the Delhi’s Directorate General of Health Services, it said.

According to the advisory, Seasonal Influenza (H1N1) is a self-limiting air-borne viral, and the disease spreads from person to person through coughing and sneezing, indirect contact by touching a contaminated object or surface, and close contact including handshakes, hugging and kissing.

Also Read- Facebook Says That it Has Changed Over Years

“The symptoms include fever and cough, sore throat, runny or stuffy nose and difficulty in breathing. Other symptoms may include body-ache, headache, fatigue, chills, diarrhea and vomiting, and blood-stained sputum,” it said.

The advisory also said that children with mild illness but with predisposing risk factors, pregnant women, persons aged 65 years or older, patients with lung diseases, heart disease, liver disease, kidney disease, blood disorders, diabetes, neurological disorders, cancer and HIV/AIDS, patients on long-term cortisone therapy are under the high-risk group. (IANS)